Gastroenterology

A new molecular classification for gastrointestinal stromal tumours has uncovered four distinct subtypes and identified a potential tumour suppressor gene.

A recent study highlights a concerning link between the use of GLP-1 receptor agonists (GLP-1RA) and inadequate bowel preparation for colonoscopies.

A recent study from Stanford Medicine highlights both promise and caution surrounding newly approved blood tests for colorectal cancer screening.

Primary sclerosing cholangitis raises colorectal cancer risk even in patients without inflammatory bowel disease, according to new findings presented at ACG 2024.

Research presented at the ACG 2024 has demonstrated high accuracy of small intestinal contrast ultrasonography (SICUS) for assessing small bowel Crohn’s disease

AI-DRIVEN endoscopic ultrasound has demonstrated high accuracy in detecting and differentiating pleomorphic pancreatic lesions, according to new research presented at the American College of Gastroenterology 2024 Annual Meeting.

Research presented at the American College of Gastroenterology (ACG) 2024 Annual Meeting showed that rifaximin monotherapy significantly reduces the risk of recurring overt hepatic encephalopathy

New research presented at the American College of Gastroenterology (ACG) Annual Meeting suggests that GLP-1 receptor agonists (GLP-1RAs) may significantly lower the risk of pancreatic cancer in patients with type 2 diabetes